Stay updated on Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page revision history has been updated: Revision: v3.3.2 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:59:46.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now displays a 'Results Submitted' indicator, and the 'No Results Posted' and the government funding status notices were removed.
    Difference
    0.5%
    Check dated 2025-11-17T17:51:50.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page; the study details and layout appear the same as before.
    Difference
    0.4%
    Check dated 2025-11-03T12:31:35.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Updated operating-status notice and page metadata to reflect current year (2025) with a new revision (v3.2.0); older 2024 timestamps and v3.1.0 were removed.
    Difference
    4%
    Check dated 2025-10-05T17:20:58.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Updated the page version from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-28T10:09:09.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Updated to v3.0.2 and removed the Back to Top element; no core content or critical information is affected.
    Difference
    0.2%
    Check dated 2025-09-14T00:25:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page.